Comera Life Sciences Holdings, Inc. Business Finance Contracts & Agreements
13 Contracts & Agreements
- Note Agreements (1 contract)
- Purchase Agreements (4)
- Registration Rights Agreements (4)
- Stock Agreements (1)
- Warrant Agreements (3)
- Securities Purchase Agreement, dated December 29, 2023, by and among Comera Life Sciences Holdings, Inc. and the Purchasers defined therein (Filed With SEC on December 29, 2023)
- Form of Common Stock Warrant (Filed With SEC on December 29, 2023)
- Form of Senior Secured Convertible Note (Filed With SEC on December 29, 2023)
- Registration Rights Agreement dated July 31, 2023, by and among the Company and the Purchasers defined therein (Filed With SEC on August 1, 2023)
- Securities Purchase Agreement, dated July 31, 2023, by and among the Company and the Purchasers defined therein (Filed With SEC on August 1, 2023)
- Form of Common Stock Warrant (Filed With SEC on August 1, 2023)
- Registration Rights Agreement dated January 4, 2023, by and among Comera Life Sciences Holdings, Inc. and the Purchasers defined therein (Filed With SEC on January 4, 2023)
- Securities Purchase Agreement, dated January 2, 2023, by and among Comera Life Sciences Holdings, Inc. and the Purchasers defined therein (Filed With SEC on January 4, 2023)
- Form of Common Stock Warrant (Filed With SEC on January 4, 2023)
- Purchase Agreement, dated August 31, 2022, between Comera Life Sciences Holdings, Inc. and Arena Business Solutions Global SPC II, Ltd (Filed With SEC on August 31, 2022)
- Registration Rights Agreement made and entered into as of May 19, 2022, between Comera Life Sciences Holdings, Inc. and Maxim Group LLC (Filed With SEC on May 25, 2022)
- Registration Rights and Lock-Up Agreement among the Registrant and certain existing stockholders of Comera and OTR, dated as of May 19, 2022 (Filed With SEC on May 25, 2022)
- Reform Biologics, Inc. 2021 Stock Option and Grant Plan (Filed With SEC on March 9, 2022)
